AR036675A1 - Indan-1-onas sustituidas en c2 y sus derivados, procedimiento para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y el uso de dichos compuestos para la preparacion de medicamentos - Google Patents
Indan-1-onas sustituidas en c2 y sus derivados, procedimiento para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y el uso de dichos compuestos para la preparacion de medicamentosInfo
- Publication number
- AR036675A1 AR036675A1 ARP020103245A ARP020103245A AR036675A1 AR 036675 A1 AR036675 A1 AR 036675A1 AR P020103245 A ARP020103245 A AR P020103245A AR P020103245 A ARP020103245 A AR P020103245A AR 036675 A1 AR036675 A1 AR 036675A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- cycloalkyl
- replaced
- cooh
- equal
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 title abstract 3
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 19
- 229910052731 fluorine Inorganic materials 0.000 abstract 14
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 12
- -1 5-tetrazolyl Chemical group 0.000 abstract 12
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 11
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 8
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 8
- 239000011737 fluorine Substances 0.000 abstract 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 8
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 7
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 5
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 abstract 4
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 4
- 229910006069 SO3H Inorganic materials 0.000 abstract 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 4
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 abstract 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 2
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 abstract 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 abstract 2
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 abstract 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 abstract 2
- KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical compound [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 abstract 2
- CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 abstract 2
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 abstract 2
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 abstract 2
- 101100516568 Caenorhabditis elegans nhr-7 gene Proteins 0.000 abstract 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 235000010290 biphenyl Nutrition 0.000 abstract 2
- 239000004305 biphenyl Substances 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 230000000578 anorexic effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10142722A DE10142722A1 (de) | 2001-08-31 | 2001-08-31 | C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR036675A1 true AR036675A1 (es) | 2004-09-29 |
Family
ID=7697277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103245A AR036675A1 (es) | 2001-08-31 | 2002-08-29 | Indan-1-onas sustituidas en c2 y sus derivados, procedimiento para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y el uso de dichos compuestos para la preparacion de medicamentos |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6762326B2 (https=) |
| EP (1) | EP1425267B1 (https=) |
| JP (1) | JP4280164B2 (https=) |
| AR (1) | AR036675A1 (https=) |
| AT (1) | ATE472525T1 (https=) |
| AU (1) | AU2002336085B2 (https=) |
| CA (1) | CA2458528C (https=) |
| DE (2) | DE10142722A1 (https=) |
| IL (1) | IL160608A0 (https=) |
| MX (1) | MXPA04001846A (https=) |
| PE (1) | PE20030360A1 (https=) |
| WO (1) | WO2003020677A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9920393D0 (en) | 1999-08-27 | 1999-11-03 | Medix Scient Uk Limited | Plant extract mixtures and their uses |
| US7659313B2 (en) | 2007-09-13 | 2010-02-09 | Gateway Health Alliances, Inc. | Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7700500L (sv) * | 1976-01-20 | 1977-07-21 | Hoechst Ag | Tiazolidinderivat och forfarande for deras framstellning |
| DE2640358A1 (de) * | 1976-09-08 | 1978-03-16 | Hoechst Ag | Thiazolidinderivate und verfahren zu ihrer herstellung |
| EP0009554B1 (de) * | 1978-07-27 | 1983-04-27 | Schering Aktiengesellschaft | Indanyl-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
| WO1989003681A1 (en) * | 1987-10-19 | 1989-05-05 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma |
| SG47557A1 (en) * | 1993-01-29 | 1998-04-17 | American Cyanamid Co | Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents |
| WO1997020802A1 (en) * | 1995-12-06 | 1997-06-12 | Venantius Limited | Indane dimer compounds and their pharmaceutical use |
| AU727775B2 (en) | 1996-01-17 | 2000-12-21 | Novo Nordisk A/S | Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| IL128332A0 (en) | 1996-08-30 | 2000-01-31 | Novo Nordisk As | GLP-1 derivatives |
| IL127296A (en) | 1996-12-31 | 2003-01-12 | Reddy Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| PL338013A1 (en) | 1997-07-16 | 2000-09-25 | Novo Nordisk As | Derivatives of condensed 1,2,4-thiadiazine, their production and application |
| DE19831878C2 (de) * | 1998-07-17 | 2001-05-17 | Aventis Pharma Gmbh | Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE19844547C2 (de) * | 1998-09-29 | 2002-11-07 | Aventis Pharma Gmbh | Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE19908539A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| FR2796070B1 (fr) * | 1999-07-06 | 2003-02-21 | Lipha | Derives de benzodiazepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation |
| EP1078632A1 (en) | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
-
2001
- 2001-08-31 DE DE10142722A patent/DE10142722A1/de not_active Withdrawn
-
2002
- 2002-08-17 JP JP2003524950A patent/JP4280164B2/ja not_active Expired - Fee Related
- 2002-08-17 AT AT02769973T patent/ATE472525T1/de active
- 2002-08-17 WO PCT/EP2002/009207 patent/WO2003020677A2/de not_active Ceased
- 2002-08-17 CA CA2458528A patent/CA2458528C/en not_active Expired - Fee Related
- 2002-08-17 IL IL16060802A patent/IL160608A0/xx unknown
- 2002-08-17 EP EP02769973A patent/EP1425267B1/de not_active Expired - Lifetime
- 2002-08-17 AU AU2002336085A patent/AU2002336085B2/en not_active Ceased
- 2002-08-17 DE DE50214511T patent/DE50214511D1/de not_active Expired - Lifetime
- 2002-08-17 MX MXPA04001846A patent/MXPA04001846A/es active IP Right Grant
- 2002-08-22 PE PE2002000806A patent/PE20030360A1/es not_active Application Discontinuation
- 2002-08-29 AR ARP020103245A patent/AR036675A1/es unknown
- 2002-08-30 US US10/231,326 patent/US6762326B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE10142722A1 (de) | 2003-03-27 |
| CA2458528A1 (en) | 2003-03-13 |
| EP1425267B1 (de) | 2010-06-30 |
| IL160608A0 (en) | 2004-07-25 |
| US20030130345A1 (en) | 2003-07-10 |
| MXPA04001846A (es) | 2004-06-15 |
| AU2002336085B2 (en) | 2007-10-11 |
| CA2458528C (en) | 2011-01-25 |
| WO2003020677A2 (de) | 2003-03-13 |
| ATE472525T1 (de) | 2010-07-15 |
| WO2003020677A3 (de) | 2003-07-31 |
| US6762326B2 (en) | 2004-07-13 |
| EP1425267A2 (de) | 2004-06-09 |
| PE20030360A1 (es) | 2003-05-16 |
| JP4280164B2 (ja) | 2009-06-17 |
| DE50214511D1 (de) | 2010-08-12 |
| JP2005525295A (ja) | 2005-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Discovery of 4-benzoyl-1-[(4-methoxy-1 H-pyrrolo [2, 3-b] pyridin-3-yl) oxoacetyl]-2-(R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions | |
| ES2899929T3 (es) | Uso de masitinib para el tratamiento de una subpoblación de pacientes con esclerosis lateral amiotrófica | |
| Kwon et al. | Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets | |
| AR032752A1 (es) | Ureido propionamidas o propionamidas heteroaromaticas trans olefinicas 2,3-di-sustituidas, un proceso para su preparacion, composiciones farmaceuticas que los comprenden y el uso de las mismas para la manufactura de un medicamento como activadores de glucoquinasa | |
| AR063047A1 (es) | Piperidinas y tetrahidropiranos sustituidos como inhibidores de la actividad de sglt2, una formulacion farmaceutica que los comprende, una unidad de dosificacion que los emplea y su utilizacion en la disminucion de la glucemia y en el tratamiento de enfermedades relacionadas. | |
| ME02315B (me) | Novi antimalarijski agensi | |
| AR072755A2 (es) | Comprimido de carga de droga alta del compuesto 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-ilamino)fenil]-benzamida | |
| PE42598A1 (es) | Composiciones farmaceuticas para el tratamiento de la rinitis | |
| US8367737B2 (en) | Method of using biothionol and biothionol-like compounds as anti-angiogenic agents | |
| AR050434A1 (es) | Derivados de ciclohexano como inhibidores de cotransportador de na+ - glucosa; composiciones farmaceuticas que los contienen como principio activo y el uso de los mismos en el tratamiento de la diabates tipo i y ii y de la obesidad | |
| AR036774A1 (es) | Derivados de sistemas de indan-1-oles sustituidos en c2, procedimiento para su preparacion, medicamentos, asi como su procedimiento de prepararcion y utilizacion de dichos compuestos para la preparacion de medicamentos | |
| CA2994162A1 (en) | Glutamine antagonists for the treatment of cognitive deficits | |
| RU2002125673A (ru) | ПРОИЗВОДНЫЕ 8,8а-ДИГИДРОИНДЕНО [1,2-d]ТИАЗОЛА, СОДЕРЖАЩИЕ В ПОЛОЖЕНИИ 2 ЗАМЕСТИТЕЛЬ С СУЛЬФОНАМИДНОЙ ИЛИ СУЛЬФОНОВОЙ СТРУКТУРОЙ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННОГО СРЕДСТВА | |
| AR036675A1 (es) | Indan-1-onas sustituidas en c2 y sus derivados, procedimiento para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y el uso de dichos compuestos para la preparacion de medicamentos | |
| RU2013148146A (ru) | Производные адамантила | |
| ES2988596T3 (es) | Métodos, compuestos y composiciones para el tratamiento de enfermedades musculoesqueléticas | |
| AR072072A1 (es) | Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669 | |
| DK1789040T3 (en) | Halogenated benzamide DERIVATIVES | |
| AR036676A1 (es) | Derivados indan-1-oles sustituidos en c2 , procedimiento para su preparacion, y su utilizacion como medicamentos, medicamento, procedimiento para la preparacion de un medicamento, uso de dichos derivados solos o en combinacion con otra sustancia activa, para la preparacion de medicamentos | |
| AR064702A1 (es) | Agonistas de receptores de proteina g heterociclicos, una composicion farmaceutica que los comprende y su uso en el tratamiento de la diabetes y trastornos metabolicos. | |
| Woodring et al. | Disrupting the conserved salt bridge in the trimerization of influenza A nucleoprotein | |
| AR032430A1 (es) | 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas, un procedimiento para su preparacion, medicamento y empleo de dichos compuestos para la manufactura de un medicamento | |
| AR031080A1 (es) | Compuestos derivados de tiazolidindiona utiles como agentes antidiabeticos, procedimientos para la preparacion, composiciones farmaceuticas y usos en la fabricacion de medicamentos. | |
| AR129415A1 (es) | Tratamiento de diabetes de tipo 2 o control del peso con ácido 2-((4-((s)-2-(5-cloropiridin-2-il)-2-metilbenzo[d][1,3]dioxol-4-il)piperidin-1-il)metil)-1-(((s)oxetan-2-il)metil)-1h-benzo[d]imidazol-6-carboxílico o una sal farmacéutica de este | |
| CN113416172A (zh) | 一种抗病毒化合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |